Pro Share Advisors LLC Puma Biotechnology, Inc. Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$1.64 - $3.3 $16,865 - $33,937	-10,284 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$2.13 - $3.24 $5,373 - $8,174	-2,523 Reduced 19.7%	10,284 $29,000
Q4 2021 Feb 08, 2022	SELL	$2.85 - $6.58 $105 - $243	-37 Reduced 0.29%	12,807 $39,000
Q3 2021 Nov 12, 2021	SELL	$6.63 - $9.39 $17,881 - $25,324	-2,697 Reduced 17.35%	12,844 $90,000
Q2 2021 Aug 13, 2021	BUY	$8.98 - $11.6 $15,948 - $20,601	1,776 Added 12.9%	15,541 $143,000
Q1 2021 May 14, 2021	BUY	$9.38 - $13.63 $7,494 - $10,890	799 Added 6.16%	13,765 $134,000
Q4 2020 Feb 09, 2021	BUY	$7.78 - $12.13 $22,017 - $34,327	2,830 Added 27.92%	12,966 $133,000
Q3 2020 Nov 13, 2020	SELL	$9.5 - $11.14 $2,907 - $3,408	-306 Reduced 2.93%	10,136 $102,000
Q2 2020 Aug 03, 2020	BUY	$7.01 - $13.24 $73,198 - $138,252	10,442 New	10,442 $109,000
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $79,096 - $183,509	-12,595 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$6.5 - $10.73 $9,353 - $15,440	-1,439 Reduced 10.25%	12,595 $110,000
Q3 2019 Nov 12, 2019	SELL	$8.75 - $12.85 $2,852 - $4,189	-326 Reduced 2.27%	14,034 $151,000
Q2 2019 Aug 13, 2019	SELL	$12.3 - $35.76 $21,648 - $62,937	-1,760 Reduced 10.92%	14,360 $183,000
Q1 2019 May 15, 2019	BUY	$20.77 - $42.37 $2,658 - $5,423	128 Added 0.8%	16,120 $625,000
Q4 2018 Feb 14, 2019	SELL	$20.07 - $46.7 $61,755 - $143,695	-3,077 Reduced 16.14%	15,992 $325,000
Q3 2018 Nov 14, 2018	SELL	$41.2 - $59.85 $27,027 - $39,261	-656 Reduced 3.33%	19,069 $874,000
Q2 2018 Aug 13, 2018	SELL	$48.3 - $68.25 $65,398 - $92,410	-1,354 Reduced 6.42%	19,725 $1.17 Million
Q1 2018 May 14, 2018	SELL	$59.7 - $99.25 $203,338 - $338,045	-3,406 Reduced 13.91%	21,079 $1.43 Million
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $2.11 Million - $2.98 Million	22,509 Added 1139.12%	24,485 $2.42 Million
Q3 2017 Nov 13, 2017	SELL	$72.0 - $119.75 $40,392 - $67,179	-561 Reduced 22.11%	1,976 $237,000
Q2 2017 Aug 11, 2017	BUY	N/A	2,537	2,537 $222,000

Others Institutions Holding PBYI

# of Institutions

100

Shares Held

29M

Call Options Held

50.6K

Put Options Held

16.3K

Vanguard Group Inc Valley Forge, PA

3.64M
Shares

$10.9 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$10.8 Million
0.0% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.06M
Shares

$9.22 Million
0.42% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.88M
Shares

$8.67 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.97M
Shares

$5.93 Million
0.02% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $137M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account